Page
%P
2 Result(s)
within
Yoshihiro Torimoto
Biomedicine
-
Article
Open AccessCytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation
Life-threatening cytomegalovirus infection (CMVI) has been reported even in patients with malignant lymphoma (ML) who have not received hematopoietic stem cell transplantation (w/o HSCT) but had been treated w...
-
Article
Open AccessMulticenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib
Nilotinib is a second-generation tyrosine kinase inhibitor that exhibits significant efficacy as first- or second-line treatment in patients with chronic myeloid leukemia (CML). We conducted a multicenter Phas...
